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ABSTRACT
Campylobacter species are increasingly being recognized as agents of gastroenteritis worldwide. However, 
data on the pathogenic characteristics of the organism isolated in rural communities in South Africa are 
lacking. In this study, the prevalence of Campylobacter spp. from diarrhoeal stools, haemolytic and haemag-
glutinating activities of the isolates, and antibiotic susceptibility profiles, including minimum inhibitory 
concentration (MIC) patterns to different antibiotics, were determined using the standard microbiological 
techniques. Campylobacter spp. were isolated from individuals of all age-groups; however, the infection 
rate was higher among individuals aged less than two years (30.4%). Of 115 Campylobacter strains isolated, 
polymerase chain reaction (PCR) analysis indicated that 98 (85%) were C. jejuni, while 17 (15%) were C. 
coli. Seventy-one (62%) of the strains showed haemolysis on human blood, and 80% agglutinated human 
blood, whereas 22.6% were β-lactamase-positive. Resistance to antimicrobials, such as erythromycin, cip-
rofloxacin, vancomycin, and fusidic acid, was high. Increased resistance to macrolide and quinolone anti-
biotics poses major risks for treatment failure. Haemolytic and haemagglutinating activities may be useful 
in preliminary characterization of pathogenic strains in settings where Campylobacter-associated infections 
are common.   
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INTRODUCTION
During the past two decades, Campylobacter species 
have been more frequently identified as bacterial 
causes of human gastroenteritis in industrialized 
and developing countries (1). In the United States, 
for example, an estimated 2.4 million cases of hu-
man campylobacteriosis occur each year, and in 
England and Wales, the majority of general practi-
tioner consultations, hospital admissions, and hos-
pital bed days were due to Campylobacter-associated 
infections (2). In Africa, a few studies have indicated 
that campylobacteriosis is mostly common among 
children of young age. In Nigeria, for example, 
Campylobacter jejuni was found to be an important 
agent of diarrhoea in Ile-Ife and should be consi-
dered strongly in children with diarrhoea (3). Stud-
ies in Addis Ababa, Ethiopia, also indicated that 
Campylobacter spp. were important bacterial agents 
of diarrhoea in adults and children and should be 
considered routinely in the diagnosis of patients 
with diarrhoea (4). In Durban, South Africa, Cam-
pylobacter were found in 21% of diarrhoeal cases 
among children aged less than five years (5). In 
Venda, Campylobacter spp. were also isolated from 
20% of stool samples tested from HIV-positive indi-
viduals (6); however, the pathogenic characteristics 
of these organisms have not been determined.
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C. coli isolates from retail meat products exhibited 
a wide range of adherence and invasion abilities to 
human intestinal epithelial cells (T84 cells) almost 
as well as did C. jejuni 81-176 with a significant cor-
relation between the adherence ability and the in-
vasion ability of Campylobacter isolates (7). Wheth-
er Campylobacter organisms produce fimbriae that 
assist in adherence and colonization still remains 
uncertain, and despite their significance as human 
pathogens, little is known about the mechanisms 
they use to cause disease. Different methods for 
the verification of the presence of fimbriae, such 
as transmission electron microscopy, adherence as-
says, haemagglutination assays, and PCR, have been 
described (8).
Although diarrhoea due to Campylobacter can be 
self-limited, a small percentage of cases require 
medical intervention with erythromycin most 
commonly prescribed. However, patients with per-
sistent diarrhoea or the immunosuppressed may 
require long-term antibiotic therapy (1). The evolu-
tion of multidrug-resistant strains also constitutes 
an important threat to the management of campy-
lobacteriosis.
In the present study, haemagglutinating and hae-
molytic activities of Campylobacter spp. isolated 
from human diarrhoeic stools on human, sheep, 
chicken and pig red blood cells, antibiograms, 
including minimum inhibitory concentrations 
(MICs), were ascertained.
MATERIALS AND METHODS
Study sites and sample collection
The study was conducted in Vhembe district from 
November 2004 to May 2005. Diarrhoeic stool 
samples were obtained from patients attending four 
major public hospitals, namely Elim, Tshilidzini, 
Siloam, and Vhufuli. Samples were collected twice 
a week and were transported in cooler bags to the 
microbiology laboratory of the University of Venda 
for analysis. Demographic information, such as age 
and sex of patients, was obtained. Information on 
their HIV status was unknown. 
Isolation and identification of organisms
Campylobacter species were isolated using the stan-
dard microbiological methods: (a) The Cape Town 
protocol which involves the use of a filter paper on 
blood agar plate without antibiotics was used. Brief-
ly, a suspension of faecal material was prepared in 
sterile saline. A 0.6 µ-m pore-size membrane filter 
(47 mm diameter) deposited on top of a Columbia 
blood agar plate supplemented with tryptose (Ox-
oid, England) was flooded with the stool emulsion. 
After 15 minutes, the filter was removed carefully 
preventing the suspension to pass to the media 
directly, so that only filtered material was inocu-
lated on the agar (9). (b) A suspension of the fae-
cal material in sterile saline was inoculated directly 
onto Skirrow’s media (10) or (c) onto a charcoal-
based media (mCCDA) using sterile swabs (10). All 
the media were purchased from Oxoid, England, 
and were prepared as indicated by the manufac-
turer. Suspected colonies that grew on all the me-
dia were confirmed by biochemical tests, including 
gram staining, oxidase, catalase, motility, and a 
Campylobacter haemagglutination kit ‘Campy Dry 
Spot’ (Oxoid, England) as recommended by the 
manufacturer.
Testing of haemolytic activity 
The haemolytic activity of Campylobacter isolates 
was tested on sheep, human, pig, and chicken blood 
agar. A single colony of each isolate was streaked 
across a blood agar plate using a sterile-inoculating 
wire loop. The inoculated blood agar plates were 
incubated at 37 ºC for 24 hours in an environment 
with a gas mixture of 10% CO2, 5% H2, and 5% O2. 
After incubation, the haemolysis was determined 
by observing haemolytic zones around the bacte-
rial growth on blood agar and scored as partial hae-
molysis or complete haemolysis. A maximum of 
six strains was tested on one plate.
Testing of haemagglutination activity 
The ability of Campylobacter isolates to aggluti-
nate human, sheep, and chicken erythrocytes was 
tested as previously described (11). Briefly, blood 
cells were washed three times in a sterile phos-
phate-buffered saline, pH 7.4 (10 mM) (PBS) and a 
3% (vol/vol) suspension was prepared in the same 
buffer immediately before use. Overnight cultures 
of Campylobacter strains, grown in Brain Heart Infu-
sion broth (Oxoid, England), were centrifuged and 
washed twice in phosphate-buffered saline (PBS) 
and equilibrated to a McFarland standard no. 1. 
Haemagglutination tests were performed at room 
temperature by mixing 20 µL of erythrocyte sus-
pension with 20 µL of bacterial suspension on a 
slide alongside a control suspension of erythrocytes 
and PBS. The slide was gently rocked by hand, and 
strains were considered positive if agglutination oc-
curred within five minutes and negative if aggluti-
nation did not occur within this period. The same 
procedure was used with lysed red blood cells from 
the same animal species. 
Inhibition of haemagglutination
The inhibition of agglutination by D-mannose 
was tested as described above, except that 20 μL of 
blood suspension was added to 20 μL of a 1% (wt/
vol) solution of D-mannose in PBS plus 20 μL of a 
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suspension containing a McFarland no. 1 of bacte-
ria in PBS. Reactions were compared with positive 
controls (20 μL of bacteria, 20 μL of PBS, and 20 μL 
of blood cells) and a negative control (40 μL of PBS 
and 20 μL of blood cells).
β-lactamase production 
β-lactamase production by Campylobacter isolates 
was detected by the nitrocefin test (12). Briefly, a 
100 mL of liquid culture grown to an OD of 0.2-
0.4, read at 600 nm, was centrifuged, and the pellet 
was washed twice in 10 mL of ice-cold phosphate 
buffer (pH 7.0) and resuspended in 1 mL of buf-
fer. The suspension was sonicated and then cen-
trifuged for 30 minutes at 10,000 g. The reaction 
was conducted in a 96-well microplate in which a 
50-μL aliquot of the supernatant was added to 10 
μL of nitrocefin. An immediate colour change from 
yellow to red was interpreted as positive for β-lac-
tamase production. 
Determination of antibiotic susceptibility by 
the disc-diffusion test
Antibiotic susceptibility of Campylobacter isolates 
to 29 antibiotics was determined using the disc-dif-
fusion technique. Information on the antibiotics 
and the disc (Oxoid, England) are shown in Table 
2. Results were interpreted according to the guidelines 
of the National Committee for Clinical Laboratory 
Standards (now known as Clinical and Laboratory 
Standards Institute) for Enterobacteriaceae (13).  
Determination of minimum inhibitory  
concentrations by microdilution
The minimum inhibitory concentration (MIC) 
patterns of the isolates to 11 antibiotics were de-
termined in microplates as previously described 
(13). Alternatively, the optical density was read in 
an ELISA reader at 495 nm. The antibiotics tested 
included gentamicin, nalidixic acid, ampicillin, 
penicillin G, erythromycin, tetracycline, kanamy-
cin, ciprofloxacin, trimethoprim, D cycloserine, 
and chloramphenicol. All antibiotics (in powder 
form) were purchased from Sigma (Heidelberg, 
Germany). 
Species distribution of Campylobacter by PCR 
analysis
To confirm the species distribution of Campylo-
bacter isolates, DNA was isolated from a fresh cul-
ture of each strain, and PCR primers, Hip 1a, and 
Hip 2b, specific to the hippuricase gene of C. jejuni 
were used (14), while the primer pairs—CC18F and 
CC519R—were used for identifying C. coli as previ-
ously described (15)  
Ethical considerations
The Research and Ethical Committee of the Uni-
versity of Venda, the Department of Health and 
Welfare, and the Department of Education in 
Polokwane, Limpopo province, South Africa, ap-
proved the study.
Statistical analysis
To determine the significance of differences in in-
fection rates, the SPSS software (version 10.1) was 
used. The differences were considered significant 
when the p value was less than 0.05.
RESULTS
Distribution of Campylobacter-associated 
infection in the study population
Of 565 stool samples collected from patients with 
diarrhoea, 290 were from females and 275 from 
males aged one month to 76 years with a median 
of 37 years. Of 69 individuals infected due to Cam-
pylobacter, the most commonly infected were 21 
individuals (30.4%) aged 0-2 year(s). The infection 
rate was higher among females (21.7%; 63/290) 
than among males (18.9%; 52/275). However, the 
difference was not statistically significant (χ2=0.690, 
p=0.406, odds ratio=0.840, 95% confidence inter-
val [CI] 0.557-1.267) even when each age-group 
was considered separately. Table 1 indicates the dis-
tribution of the study population by age-group and 
sex and also by the infection rate of Campylobacter 
spp.      
Haemolytic and haemagglutination  
activities and β-lactamase production of 
Campylobacter isolates
Seventy-one (61%) of the Campylobacter isolates 
showed haemolytic activity on human red blood 
cells, and these comprised 18 (15.7%) with partial 
haemolysis and 53 (46.1%) with complete haemo-
lysis. Pig blood was less sensitive to haemolysis by 
Campylobacter spp. with 17.4% showing complete 
haemolysis, whereas 42% of the isolates were hae-
molytic on chicken and sheep red blood cells. 
Two types of haemagglutination were observed: 
one that was inhibited by mannose–termed type 1 
and one that was not inhibited by mannose–termed 
type 3 (16). About 92 (80%) of the isolates demon-
strated haemagglutinating activity on chicken and 
human red blood cells, 21% of which were inhibi-Samie A et al. Antibiotic susceptibility profiles of Campylobacter spp.
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ted by mannose, and 59% were not inhibited by 
mannose. Sheep blood was resistant to haemagglu-
tination. 
Twenty-six (22.6%) of 115 Campylobacter spp. iso-
lated from human diarrhoeal stools were beta-lac-
tamase-positive. 
Antibiotic susceptibility profiles and distribu-
tion of MICs of different antibiotics 
Table 2 shows the results of antibiotic susceptibil-
ity testing of the Campylobacter isolates to the 29 
antibiotics studied, the antibiotic content of the 
discs, the code name of the antibiotics, and the re-
sistance breakpoints used. The patterns of MICs of 
11 antibiotics on the Campylobacter isolates were 
determined with concentrations varying from 0.25 
μg/mL to 128 μg/mL as indicated on Table 2.  
Confirmation of species distribution by PCR
Of all the 115 isolates tested for both C. jejuni and 
C. coli by PCR, 98 (85%) were C. jejuni, and 17 
(15%) were C. coli. The figure shows the electropho-
resis gels of the PCR products for C. jejuni and C. 
coli. 
DISCUSSION
The aim of this study was to isolate Campylobacter 
spp. from diarrhoeal stool samples obtained from 
patients attending major hospital centres in Vhem-
be district and to determine their characteristics 
in terms of haemolysis, haemagglutination, ß-lac-
tamase production, and antibiotic susceptibility 
profiles. We found a higher rate of infection 
among children aged less than two years, similar 
to the results obtained from other studies, such as 
those undertaken in Barbados that indicated the 
highest rate of isolation in children aged 1-4 year(s) 
(40.8%) (17). Results of recent studies in Kenya and 
Spain also indicated a higher prevalence of Cam-
pylobacter spp. among children aged less than five 
years (18,19). It is, thus, important that control pro-
grammes targeting the elimination of infections 
due to Campylobacter consider children as a priority 
since they might be more vulnerable to infections 
than adults.
Haemolysis has been determined as a pathogenic 
factor in Campylobacter spp. and is associated 
with inflammatory Campylobacter strains (20). We 
found that 62% of the Campylobacter strains were 
haemolytic on human blood. This compares with 
results of previous studies which indicated that 17 
(71%) of 24 human and 61 (63%) of 97 pig isolates 
showed haemolytic activity on sheep blood (21).  It 
has been suggested that the adherence capacity and 
cytotoxicity could be used as virulence markers and 
for predicting the inflammatory or secretory nature 
of C. jejuni-induced diarrhoea. (20). In the present 
study, we could not differentiate between different 
types of diarrhoea; however, the high rate of hae-
molytic strains on human blood may indicate the 
inflammatory characteristics of these strains. Pro-
found haemolytic activities against human blood 
as opposed to pig blood were noted. Hossain et al. 
demonstrated that Campylobacter strains produced 
one or more haemolysin(s) with maximum activity 
against rabbit erythrocytes and minimal activity 
against chicken erythrocytes (22). This also indi-
cates the different degrees of susceptibility of differ-
Table 1. Distribution of study population by age-group and sex and also by rate of isolation of  




















0-2 33 (12) 9 (27.3) 36 (12.4) 12 (33.3) 69 (12.2) 21 (30.4)
3-5 22 (8) 2 (9) 25 (8.6) 6 (24) 47 (8.3) 8 (17)
6-9 30 (11) 6 (20) 21 (7.2) 4 (19) 51 (9) 10 (19.6)
10-19 34 (12.4) 3 (8.8) 38 (13.1) 5 (13.1) 72 (12.7) 8 (11.1)
20-29 46 (16.7) 11 (23.9) 52 (18) 10 (19.2) 98 (17.3) 21 (21.4)
30-39 47 (17) 12 (25.5) 48 (16.6) 8 (16.7) 95 (16.8) 20 (21)
40-49 41 (15) 8 (19.5) 42 (14.5) 12 (28.6) 83 (14.7) 20 (24.1)
50-60 12 (4.4) 1 (8.3) 16 (5.5) 4 (25) 28 (5) 5 (17.8)
>60 10 (3.6) 0 (0) 12 (4.1) 2 (16.7) 22 (3.9) 2 (9)
Total 275 (48.7) 52 (18.9) 290 (51.3) 63 (21.7) 565 (100) 115 (20.3)Samie A et al. Antibiotic susceptibility profiles of Campylobacter spp.
JHPN 410












Penicillins Penicillin G PG 10 ≤14 115 (100) ≥128 µg/mL–8 µg/mL
Amoxicillin A 10 ≤13 115 (100) ND
Cloxacillin CX   5 ≤13 103 (89.6) ND
Ampicillin  AP 10 ≤13 94 (81.2) ≥128 µg/mL–8 µg/mL
Cephalosporines  Cephazoline 1st  CZ 30 ≤14 77 (67) ND
Cefuroxime 2nd  CXM 30 ≤14 87 (76) ND
Cefoxitin 2nd  FOX 30 ≤14 36 (31.4) ND
Cefotaxime 3rd  CTX 30 ≤14 33 (28.7) ND
Ceftriaxone 3rd  CRO 30 ≤14 8 (7) ND
Cefepime 4th  CPM 30 ≤14 9 (8) ND
Carbapenems Meropenem MEM 10 ≤13 11 (9.6) ND
Imipenem IMI 10 ≤13 13 (11.3) ND
Quinolones Nalidixic acid NA 30 ≤13 59 (51.3) 128 µg/mL–1 µg/mL
Ciprofloxacin CIP   5 ≤15 15 (13) 32 µg/mL–0.25 µg/mL
Lomefloxacin Lom 10 ≤13 17 (14.8) ND
Aminoglycosides Gentamicin GM 10 ≤12 20 (17.3) 32 µg/mL–0.25 µg/mL
Amikacin  AK 30 ≤14 20 (17.4) ND
Kanamycin  K 30 ≤14 21 (18.3) 32 µg/mL–0.25 µg/mL
Tetracyclines Tetracycline T 30 ≤14 31 (27) 64 µg/mL–0.25 µg/mL
Doxycycline DXT 30 ≤12 46 (40) ND
Macrolides Erythromycin E 15 ≤13 61 (53) 64 µg/mL–0.5 µg/mL
Glycopeptide Vancomycin VA 30 ≤14 115 (100) ND
Others Fusidic acid FC 10 ≤14 113 (98) ND
Rifampicin RP 5 ≤13 86 (75) ND
Chloramphenicol C 30 ≤12 24 (21) 128 µg/mL–0.5 µg/mL
Augmentin AUG 30 ≤14 96 (83) ND
Nitrofurantoin NI 300 ≤14 76 (66.1) ND
Novobiocin NO 5 ≤14 115 (100) ND
Co-trimoxazole TS 20 ≤13 42 (36.5) ND
Trimethoprim TRP - - ND ≥128 µg/mL–64 µg/mL
D-cycloserine  DCS - - ND  4 µg/mL–0.25 µg/mL
ATB=Antibiotics; Con=Antibiotic content of the disc; MIC=Minimum inhibitory concentration; ND=Not 
done; RBP=Resistance break-point
ent animal species to Campylobacter-associated in-
fections and the increased susceptibility of humans 
to these Campylobacter strains.  
The major therapeutic intervention for all individu-
als with diarrhoea consists of fluid and electrolyte 
therapy. However, the use of antibiotics may help 
shorten the duration of diarrhoea and speed recov-
ery. In the case of Campylobacter, the drugs of choice 
include macrolide and fluoroquinolones. However, 
resistance to these and other antibiotics has been 
reported around the world. In the Venda region, 
the site of our study, the resistance of Campylobacter 
spp. to erythromycin has been increasing steadily. 
In 2002, Obi and Bessong reported a resistance lev-
el of 25% (6), and in 2004, Obi et al. reported a re-
sistance level of 35% (23). In the present study, we 
found a resistance level of 53%. The same was also 
noted for resistance to ciprofloxacin (8%) (6)—4% 
in 2004 (23), and we found 13% resistance in the Samie A et al. Antibiotic susceptibility profiles of Campylobacter spp.
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A    
500 bp
 500 bp 
 200 bp
PCR=Polymerase chain reaction
M       1       2       3       4      Cj     Cc     M
M      1       2       3      4        5      Cj     Cc
B 
Fig. PCR conﬁrmation of Campylobacter isolates. A: Hippuricase gene PCR products for conﬁrmation 
of C. jejuni; M=DNA ladder 1, 2, and 4 are isolates positive for C. jejuni, 3=Negative control, Cj=C. 
jejuni (ATCC 33560) and Cc=C. coli (ATCC 33559) used as positive controls. B: PCR products for 
conﬁrmation of C. coli: 1, 2, 3, 4, and 5 are strains positive for C. coli
present study. Resistance to gentamicin rose from 
8% in 2002 to 12% in 2004, and it was 17.3% in 
the present study. Increasing resistance constitutes 
a great risk of treatment failure and underscores 
the importance of monitoring antibiotics and the 
quest for alternative strategies to treat bacterial in-
fections. Rates of similar resistance have also been 
reported from other parts of the world. In England 
and Wales, over half (55%) of Campylobacter-associa-
ted infections acquired abroad (Spain, Portugal, or 
Cyprus) were resistant to ciprofloxacin compared 
to 10% of UK-acquired strains (24). In Ireland, re-
sistance among human Campylobacter isolates was 
6.4%, 12%, and 13% to erythromycin, ciprofloxa-
cin, and tetracycline respectively, with minor dif-
ferences between C. jejuni and C. coli strains (1). 
In Senegal, Cardinale et al. observed high rates of 
quinolone-resistance for C. jejuni (43.4%) and C. 
coli  (48.6%)  isolates  obtained  from  poultry  (25). 
However, the antibiotic resistance of Campylobacter 
isolates in meat products has not been studied in 
the Venda region of South Africa, and conducting Samie A et al. Antibiotic susceptibility profiles of Campylobacter spp.
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similar studies on poultry would enhance our un-
derstanding of their possible role in antibiotic resis-
tance. When antimicrobial therapy is indicated, the 
selection of a specific agent should be made based 
upon the susceptibility patterns of the pathogen or 
information on local susceptibility patterns (26).
Finally, the study has provided baseline data on the 
prevalence, antibiograms, and some pathogenic 
factors among Campylobacter isolates and is, there-
fore, of clinico-epidemiological significance. 
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